Patents by Inventor Kendrick Goss

Kendrick Goss has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200071721
    Abstract: The invention provides compositions and methods for treating Hunter Syndrome.
    Type: Application
    Filed: December 6, 2017
    Publication date: March 5, 2020
    Applicant: bluebird bio, Inc.
    Inventors: Kendrick A. GOSS, Geoffrey B. PARSONS
  • Patent number: 9012238
    Abstract: Implantable devices comprise at least one or more targeting molecules that form a primary coating layer for selectively recruiting, isolating, activating, and/or eliminating any cells of interest, such as T cells, monocytes, and stem cells. The implantable devices can be utilized for selectively removing a particular subset of cells from bodily fluids of a patient. Various non-selective pharmaceutical agents and biological agents can be incorporated into the implantable devices so that cells of interest can be isolated for elimination or for activation/differentiation. Cell-type selectivity is conferred by the presence of cell-type-specific targeting molecules incorporated into the implantable device, preferably at the surface level to permit direct or indirect interaction between the cells of interest and targeting molecules of the implantable device. Related therapeutic methods for utilizing the implantable devices are also provided.
    Type: Grant
    Filed: January 31, 2007
    Date of Patent: April 21, 2015
    Assignee: Biomed Solutions, LLC
    Inventors: Kendrick Goss, Carol Gebert
  • Publication number: 20120185016
    Abstract: Disclosed in this specification is an apparatus and method for treating a biological organism comprising a device for emitting and delivering energy to the biological organism, a programmable controller for varying the type and amount of energy emitted, and apparatus for sensing a condition of the biological organism.
    Type: Application
    Filed: December 20, 2011
    Publication date: July 19, 2012
    Applicant: Biomed Solutions LLC
    Inventors: Michael L. Weiner, Robert W. Gray, Stuart G. MacDonald, Jack A. Tuszynski, Amara D. Angelica, Kendrick Goss
  • Publication number: 20110054347
    Abstract: Implantable devices comprise at least one or more targeting molecules that form a primary coating layer for selectively recruiting, isolating, activating, and/or eliminating any cells of interest, such as T cells, monocytes, and stem cells. The implantable devices can be utilized for selectively removing a particular subset of cells from bodily fluids of a patient. Various non-selective pharmaceutical agents and biological agents can be incorporated into the implantable devices so that cells of interest can be isolated for elimination or for activation/differentiation. Cell-type selectivity is conferred by the presence of cell-type-specific targeting molecules incorporated into the implantable device, preferably at the surface level to permit direct or indirect interaction between the cells of interest and targeting molecules of the implantable device. Related therapeutic methods for utilizing the implantable devices are also provided.
    Type: Application
    Filed: January 31, 2007
    Publication date: March 3, 2011
    Applicant: BIOMED SOLUTIONS LLC
    Inventors: Kendrick Goss, Carol Gebert
  • Publication number: 20080287856
    Abstract: An apparatus for treating a biological organism comprising a device for emitting and delivering energy to the biological organism, a programmable controller for varying the type and amount of energy emitted, and apparatus for sensing a condition of the biological organism.
    Type: Application
    Filed: June 10, 2008
    Publication date: November 20, 2008
    Applicant: Biomed Solutions LLC
    Inventors: Stuart G. MacDonald, Jack A. Tuszynski, Kendrick Goss, Michael L. Weiner, Robert W. Gray, Amara D. Angelica
  • Publication number: 20080119421
    Abstract: A process for treating a biological organism, comprising the steps in which a cell cycle arresting drug is administered to the organism to produce synchronized cells, the microtubules within the synchronized cells are stabilized by means of a microtubule stabilizing agent, and the synchronized cells with the stabilized microtubules are then contacted with mechanical vibrational energy.
    Type: Application
    Filed: October 28, 2004
    Publication date: May 22, 2008
    Inventors: Jack Tuszynski, Howard J. Greenwald, Stephen H. Curry, Kendrick Goss
  • Publication number: 20070149496
    Abstract: A water-soluble magnetic anti-mitotic compound with a water-solubility of at least 100 micrograms per milliliter, a molecular weight of at least 150 grams per mole, a mitotic index factor of at least 10 percent, a positive magnetic susceptibility of at least 1,000×10?6 cgs, and a magnetic moment of at least 0.5 bohr magnetrons, wherein said compound is comprised of at least 7 carbon atoms and at least one inorganic atom with a positive magnetic susceptibility of at least 200×10?6 cgs.
    Type: Application
    Filed: August 20, 2004
    Publication date: June 28, 2007
    Inventors: Jack Tuszynski, Howard Greenwald, Stephen Curry, Kendrick Goss
  • Publication number: 20070092549
    Abstract: A water-soluble magnetic anti-mitotic compound with a water-solubility of at least 100 micrograms per milliliter, a molecular weight of at least 150 grams per mole, a mitotic index factor of at least 10 percent, a positive magnetic susceptibility of at least 1,000×10?6 cgs, and a magnetic moment of at least 0.5 bohr magnetrons, wherein said compound is comprised of at least 7 carbon atoms and at least one inorganic atom with a positive magnetic susceptibility of at least 200×10?6 cgs.
    Type: Application
    Filed: February 23, 2005
    Publication date: April 26, 2007
    Inventors: Jack Tuszynski, Howard Greenwald, Stephen Curry, Kendrick Goss
  • Publication number: 20070027129
    Abstract: A water-soluble magnetic anti-mitotic compound with a water-solubility of at least 100 micrograms per milliliter, a molecular weight of at least 150 grams per mole, a mitotic index factor of at least 10 percent, a positive magnetic susceptibility of at least 1,000×10?6 cgs, and a magnetic moment of at least 0.5 bohr magnetrons, wherein said compound is comprised of at least 7 carbon atoms and at least one inorganic atom with a positive magnetic susceptibility of at least 200×10?6 cgs.
    Type: Application
    Filed: February 23, 2005
    Publication date: February 1, 2007
    Inventors: Jack Tuszynski, Howard Greenwald, Stephen Curry, Kendrick Goss
  • Publication number: 20060147371
    Abstract: A water-soluble magnetic anti-mitotic compound with a water-solubility of at least 100 micrograms per milliliter, a molecular weight of at least 150 grams per mole, a mitotic index factor of at least 10 percent, a positive magnetic susceptibility of at least 1,000×10?6 cgs, and a magnetic moment of at least 0.5 bohr magnetrons, wherein said compound is comprised of at least 7 carbon atoms and at least one inorganic atom with a positive magnetic susceptibility of at least 200×10?6 cgs.
    Type: Application
    Filed: February 23, 2005
    Publication date: July 6, 2006
    Inventors: Jack Tuszynski, Howard Greenwald, Stephen Curry, Kendrick Goss
  • Publication number: 20050249667
    Abstract: A process for treating cells within a biological organism in which sonic energy is focused on cells within a biological organism while the frequency and/or the power level of such energy is varied. In addition there is provided a process for synergistically combining sonic energy and other forms of energy, or other therapeutic agents, in the treatment of cells in living organisms. Furthermore there is provided a process for assaying the efficacy of other therapeutic agents with sonic energy.
    Type: Application
    Filed: June 7, 2005
    Publication date: November 10, 2005
    Inventors: Jack Tuszynski, Kendrick Goss, Howard Greenwald, Garold Fritz
  • Publication number: 20050215764
    Abstract: A biological polymer assembly with a biological polymer that contains at least 90 percent of tubulin and a positively charged segment. The positively charged segment has a molecular weight of at least about 5,000 Daltons, a bulk electrical conductivity of at least about 10?7 ohms?1 meter?1 Siemens, a concentration of elemental charges per cubic centimeter of from about 1012 to about 1025, and a length of at least about 2 nanometers.
    Type: Application
    Filed: February 18, 2005
    Publication date: September 29, 2005
    Inventors: Jack Tuszynski, Kendrick Goss, Howard Greenwald
  • Publication number: 20050203578
    Abstract: An apparatus for treating a biological organism comprising a device for emitting and delivering energy to the biological organism, a programmable controller for varying the type and amount of energy emitted, and apparatus for sensing a condition of the biological organism.
    Type: Application
    Filed: February 25, 2005
    Publication date: September 15, 2005
    Inventors: Michael Weiner, Robert Gray, Stuart MacDonald, Jack Tuszynski, Kendrick Goss, Amara Angelica